Basilea Pharmaceutica AG (SWX: BSLN)

Basilea Pharmaceutica AG Ratios and Metrics

Market cap in millions CHF. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 4, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	552	128	54	63	66	55
Market Cap Growth	761.67%	138.81%	-14.90%	-4.70%	20.42%	59.08%
Enterprise Value	602	114	34	38	54	45
Last Close Price	45.55	3.49	1.47	1.93	2.02	2.26
PE Ratio	-	-9.18	-3.41	-8.37	-4.26	-3.17
PS Ratio	3.68	3.82	2.99	4.57	16.40	21.48
PB Ratio	32.89	2.26	0.78	0.82	0.78	0.71
P/FCF Ratio	59.14	-14.00	-6.94	-10.95	-7.12	-5.03
P/OCF Ratio	-181.89	-14.51	-7.31	-11.56	-7.17	-5.07
EV/Sales Ratio	4.04	3.41	1.90	2.77	13.27	17.71
EV/EBITDA Ratio	-140.09	-17.42	-4.55	-6.04	-5.65	-5.06
EV/EBIT Ratio	-91.16	-13.20	-3.46	-4.37	-4.55	-3.98
EV/FCF Ratio	64.45	-12.48	-4.40	-6.65	-5.76	-4.15
Debt / Equity Ratio	0.03	0.04	0.03	0.03	0.03	0.03
Debt / FCF Ratio	-0.60	-0.24	-0.26	-0.38	-0.26	-0.22
Asset Turnover	0.68	0.43	0.21	0.15	0.04	0.03
Inventory Turnover	1.14	1.27	1.47	2.33	1.96	2.96
Quick Ratio	2.08	1.66	2.20	2.72	7.69	6.01
Current Ratio	2.73	2.06	2.49	2.91	8.76	6.40
Return on Equity (ROE)	-14.32%	-21.86%	-20.02%	-9.33%	-14.18%	-14.58%
Return on Assets (ROA)	-3.77%	-7.01%	-7.06%	-5.90%	-8.09%	-8.20%
Return on Capital (ROIC)	-4.54%	-8.34%	-8.20%	-6.59%	-8.81%	-9.08%
Earnings Yield	-0.12%	-10.70%	-27.17%	-11.95%	-17.39%	-20.45%
FCF Yield	1.69%	-7.14%	-14.41%	-9.13%	-14.04%	-19.88%
Buyback Yield / Dilution	17.17%	-7.91%	-3.37%	-34.86%	-53.69%	-81.36%
Total Shareholder Return	17.17%	-7.91%	-3.37%	-34.86%	-53.69%	-81.36%

Source: S&P Capital IQ. Standard template. Financial Sources.